These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36253957)

  • 1. Current trends in the use of human serum albumin for drug delivery in cancer.
    Paul M; Itoo AM; Ghosh B; Biswas S
    Expert Opin Drug Deliv; 2022 Nov; 19(11):1449-1470. PubMed ID: 36253957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Uniqueness of Albumin as a Carrier in Nanodrug Delivery.
    Spada A; Emami J; Tuszynski JA; Lavasanifar A
    Mol Pharm; 2021 May; 18(5):1862-1894. PubMed ID: 33787270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reverse-QTY code design of active human serum albumin self-assembled amphiphilic nanoparticles for effective anti-tumor drug doxorubicin release in mice.
    Meng R; Hao S; Sun C; Hou Z; Hou Y; Wang L; Deng P; Deng J; Yang Y; Xia H; Wang B; Qing R; Zhang S
    Proc Natl Acad Sci U S A; 2023 May; 120(21):e2220173120. PubMed ID: 37186820
    [No Abstract]   [Full Text] [Related]  

  • 4. Albumin Nanoparticle-Based Drug Delivery Systems.
    Qu N; Song K; Ji Y; Liu M; Chen L; Lee RJ; Teng L
    Int J Nanomedicine; 2024; 19():6945-6980. PubMed ID: 39005962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood-Brain-Barrier-Penetrating Albumin Nanoparticles for Biomimetic Drug Delivery via Albumin-Binding Protein Pathways for Antiglioma Therapy.
    Lin T; Zhao P; Jiang Y; Tang Y; Jin H; Pan Z; He H; Yang VC; Huang Y
    ACS Nano; 2016 Nov; 10(11):9999-10012. PubMed ID: 27934069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin nanoscience: homing nanotechnology enabling targeted drug delivery and therapy.
    Lamichhane S; Lee S
    Arch Pharm Res; 2020 Jan; 43(1):118-133. PubMed ID: 31916145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface modification of polymer nanoparticles with native albumin for enhancing drug delivery to solid tumors.
    Hyun H; Park J; Willis K; Park JE; Lyle LT; Lee W; Yeo Y
    Biomaterials; 2018 Oct; 180():206-224. PubMed ID: 30048910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Albumin nanostructures as advanced drug delivery systems.
    Karimi M; Bahrami S; Ravari SB; Zangabad PS; Mirshekari H; Bozorgomid M; Shahreza S; Sori M; Hamblin MR
    Expert Opin Drug Deliv; 2016 Nov; 13(11):1609-1623. PubMed ID: 27216915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulating the tumoral SPARC content to enhance albumin-based drug delivery for cancer therapy.
    Zheng B; Chen Y; Niu L; Zhang X; Yang Y; Wang S; Chen W; Cai Z; Huang W; Huang W
    J Control Release; 2024 Feb; 366():596-610. PubMed ID: 38184232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug Delivery Vehicles Based on Albumin-Polymer Conjugates.
    Jiang Y; Stenzel M
    Macromol Biosci; 2016 Jun; 16(6):791-802. PubMed ID: 26947019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.
    Li F; Zheng C; Xin J; Chen F; Ling H; Sun L; Webster TJ; Ming X; Liu J
    Int J Nanomedicine; 2016; 11():3875-90. PubMed ID: 27574421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation, characterization and targeting of micronized 10-hydroxycamptothecin-loaded folate-conjugated human serum albumin nanoparticles to cancer cells.
    Li Q; Liu C; Zhao X; Zu Y; Wang Y; Zhang B; Zhao D; Zhao Q; Su L; Gao Y; Sun B
    Int J Nanomedicine; 2011; 6():397-405. PubMed ID: 21499429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer nano-delivery systems based on bovine serum albumin nanoparticles: A critical review.
    Solanki R; Rostamabadi H; Patel S; Jafari SM
    Int J Biol Macromol; 2021 Dec; 193(Pt A):528-540. PubMed ID: 34655592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assembled non-covalent protein-drug nanoparticles: an emerging delivery platform for anti-cancer drugs.
    Hassanin IA; Elzoghby AO
    Expert Opin Drug Deliv; 2020 Oct; 17(10):1437-1458. PubMed ID: 32820954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative and Injectable Preformed Albumin-Bound Anticancer Drug Delivery System for Anticancer and Antimetastasis Treatment.
    Zhou C; Song X; Guo C; Tan Y; Zhao J; Yang Q; Chen D; Tan T; Sun X; Gong T; Zhang Z
    ACS Appl Mater Interfaces; 2019 Nov; 11(45):42534-42548. PubMed ID: 31479235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pH and redox dual responsive carrier-free anticancer drug nanoparticles for targeted delivery and synergistic therapy.
    Zhou M; Wei W; Chen X; Xu X; Zhang X; Zhang X
    Nanomedicine; 2019 Aug; 20():102008. PubMed ID: 31121311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting sialic acid residues on lung cancer cells by inhalable boronic acid-decorated albumin nanocomposites for combined chemo/herbal therapy.
    Elgohary MM; Helmy MW; Abdelfattah EA; Ragab DM; Mortada SM; Fang JY; Elzoghby AO
    J Control Release; 2018 Sep; 285():230-243. PubMed ID: 30009892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Albumin-Based Nanodevices as Drug Carriers.
    Loureiro A; Azoia NG; Gomes AC; Cavaco-Paulo A
    Curr Pharm Des; 2016; 22(10):1371-90. PubMed ID: 26806342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An organic solvent-free technology for the fabrication of albumin-based paclitaxel nanoparticles for effective cancer therapy.
    Zhao Y; Cai C; Liu M; Zhao Y; Pei W; Chu X; Zhang H; Wang Z; Han J
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110394. PubMed ID: 31398618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in hyaluronic acid-based nanomedicine for targeted cancer treatment.
    Rao NV; Yoon HY; Han HS; Ko H; Son S; Lee M; Lee H; Jo DG; Kang YM; Park JH
    Expert Opin Drug Deliv; 2016; 13(2):239-52. PubMed ID: 26653872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.